Newcelx
NewCelX Ltd.(Nasdaq: NCEL) is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company’s integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. NewCelX is headquartered in Zurich, Switzerland, with research and development operations in Ness Ziona, Israel.
7-day free trial · no credit card
Verified contacts
12
available on Kipplo
LinkedIn employees
30
11 to 50 range
Open roles
—
no listings
Distinct roles
12
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 12 verified contacts at Newcelx
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
12 contacts with verified email or phone · masked until revealed.
- SB
Sarah Bazak
Kadimastem Ltd · Science
EmailPhone - EK
Eric Konofal
Head of Doxa Program · Other
EmailPhone
Showing 2 of 12 verified contacts
Top roles at Newcelx
12 distinct titles indexed · top 10 shown.
- 1clinical project manager
- 1director of quality
- 1executive vp for research & development
- 1external director,
- 1head of diabetes research
- 1head of doxa program
- 1kadimastem ltd
- 1nls pharmaceutics
- 1owner, aviation & international affairs consultant
- 1reaserch assistant
- +2more titles
Sign up to unlock all 12 contacts at Newcelx
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 12 verified contacts at Newcelx
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.